NEWS

Share 0
Like 0
Adipogenic and Metabolic Effects of Antipsychotic Drugs | Nutrition & Obesity Research Center

Adipogenic and Metabolic Effects of Antipsychotic Drugs | Nutrition & Obesity Research Center

Conference
Monday 7/11/2011 - Tuesday 7/12/2011

Hilton Newark Airport
1170 Spring Street
Elizabeth, NJ 07201
Though possessing many advantages, many Antipsychotic drugs (APDs) have a major liability in their ability to promote adiposity, obesity, and metabolic dysregulation in an already metabolically vulnerable population. The past decade has witnessed substantial research effort aimed at quantifying, understanding, preventing, and alleviating these adverse effects and our goal is to provide a scientific update of these findings and discuss future research needs.

Organizing Committee:

David Allison, Ph.D.
University of Alabama at Birmingham

John Newcomer, M.D.
Miller School of Medicine, University of Miami

Christoph Correll, M.D.
Albert Einstein College of Medicine

Gary Remington MD PhD FRCPC
Centre for Addiction and Mental Health (CAMH), Canada

Elaine H. Morrato, DrPH MPH CPH
University of Colorado Denver
Share 0
Like 0

You are in

Health